Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:36:24.033Z.
Calculation as of: 2026-10-06T16:36:24.033Z.
Quote observation: 2026-10-06T16:34:42.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 26be04fabca1f5abb96b6b094ab833c4d2e2f23bc88365d6eea621c26c981704
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Corbus Pharmaceuticals Holdings, Inc.
Market Cap
$107.65M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.50M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.30M
Operating Cash Flow Yield
N/A
TTM Avg
12.54%
3Y Avg
12.54%
5Y Avg
12.54%
Market Cap
$109.49M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.36M
Operating Cash Flow Yield
0.69%
TTM Avg
8.27%
3Y Avg
16.31%
5Y Avg
18.05%
Market Cap
$111.61M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.52M
Operating Cash Flow Yield
39.26%
TTM Avg
38.13%
3Y Avg
19.19%
5Y Avg
12.42%
Market Cap
$110.27M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $107.65M | N/A | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $108.02M | N/A | N/A | N/A | N/A |
| Outlook Therapeutics, Inc. (OTLK)vs › | $108.50M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.30M | N/A | 12.54% | 12.54% | 12.54% |
| Apyx Medical Corporation (APYX)vs › | $109.49M | N/A | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.36M | 0.69% | 8.27% | 16.31% | 18.05% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $111.61M | N/A | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $105.52M | 39.26% | 38.13% | 19.19% | 12.42% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $110.27M | N/A | N/A | N/A | N/A |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
